Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 5:17:17562848241279105.
doi: 10.1177/17562848241279105. eCollection 2024.

The impact of periampullary diverticula on cannulation and adverse events in endoscopic retrograde cholangiopancreatography

Affiliations

The impact of periampullary diverticula on cannulation and adverse events in endoscopic retrograde cholangiopancreatography

Arvid Gustafsson et al. Therap Adv Gastroenterol. .

Abstract

Background: Periampullary diverticulum (PAD) is commonly encountered in endoscopic retrograde cholangiopancreatography (ERCP) procedures.

Objectives: We sought to determine whether PADs are associated with a lower success rate of cannulation and an increased risk of adverse events.

Design: A retrospective cohort study was conducted using prospectively gathered nationwide registry data.

Methods: Using the Swedish registry for gallstone surgery and ERCP, we analyzed a cohort of 66,974 prospectively registered ERCP procedures performed in 2006-2021. The presence of PAD was divided into two groups based on the PAD type: Boix type 1 (the papilla located inside the PAD) and Boix types 2-3 (the papilla located either at the edge of the PAD or immediately adjacent to the PAD). The primary outcomes were the success rate of cannulation and overall adverse events within 30 days.

Results: PADs were registered in 8130 (12.1%) of ERCPs included in the study population. In total, 2114 (3.9%) patients had Boix type 1 PAD, while 5035 (8.2%) patients had Boix type 2 or 3 PAD. The chance of successful cannulation was lower in patients with type 1 PAD compared to no PAD (80.1% vs 88.7%; odds ratio: 0.42, 95% confidence interval: 0.38-0.46). No differences were seen in overall adverse events or post-ERCP pancreatitis. Adverse events occurred in 14.6% of patients with PAD type 1 and 16.0% of patients with PAD type 2 or 3, compared to 16.5% of patients without a PAD.

Conclusion: Cannulation appears less successful during ERCP when the papilla is located in the PAD (i.e., type 1). Adverse events seem not to increase with the presence of a PAD, but they could theoretically be influenced by the inability to cannulate.

Keywords: ERCP; adverse events; cannulation; duodenal diverticula; endoscopic retrograde cholangiopancreatography; periampullary diverticulum.

Plain language summary

How a pouch in the duodenum affects the difficulty and complications of an endoscopic procedure investigating the bile ducts A duodenal diverticulum (pouch in the duodenum) is a common finding during endoscopic examinations. A diverticulum can make it harder to do an ERCP, which is an endoscopic procedure that examines the bile ducts. The diverticulum might make it harder to do an ERCP because it affects the opening where the bile is released into the intestine. If the bile duct opening is inside the diverticulum, it is classified as type 1. If it is on the edge or outside, it is classified as type 2-3. This study used Swedish registry data to see if these types of diverticula make ERCP harder and cause more problems after the procedure. 47,486 procedures were investigated, and 12.1% had a diverticulum. A type 1 diverticulum makes ERCP harder. There was no difference in complications between the types of diverticula and no diverticulum. This means a diverticulum does not raise the risk of complications during ERCP. However, for a type 1 diverticulum, not being able to perform ERCP may prevent complications.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest.

Figures

Figure 1.
Figure 1.
This flow chart illustrates the total number of procedures with PAD in the registry, the exclusion of certain procedures, and the categorization of PAD subtypes. PAD, periampullary diverticulum.
Figure 2.
Figure 2.
Odds ratio plot presenting the comparison of primary outcomes and specific adverse events between those with a PAD and those without. Furthermore, a separate comparison is displayed between various subtypes of PAD and no PAD. For details regarding the regression models see the Supplementary online material. aAdjusted for sex, age, ASA, indication, acute, or elective setting. bAdjusted for sex, age, ASA, precut, indication, acute, or elective setting, procedure time. cAdjusted for sex, age, ASA, precut, indication, acute, or elective setting, procedure time. dAdjusted for sex, age, precut, indication, procedure time. eAdjusted for sex, age, ASA, precut, indication, acute, or elective setting, procedure time. fAdjusted for sex, age, precut, indication, procedure time. CI, confidence interval; PAD, periampullary diverticulum.

Similar articles

Cited by

References

    1. Jayaraj M, Mohan BP, Dhindsa BS, et al.. Periampullary diverticula and ERCP outcomes: a systematic review and meta-analysis. Dig Dis Sci 2019; 64: 1364–1376. - PubMed
    1. Mu P, Yue P, Li F, et al.. Does periampullary diverticulum affect ERCP cannulation and post-procedure complications? An up-to-date meta-analysis. Turk J Gastroenterol 2020; 31: 193–204. - PMC - PubMed
    1. Shemesh E, Klein E, Czerniak A, et al.. Endoscopic sphincterotomy in patients with gallbladder in situ: the influence of periampullary duodenal diverticula. Surgery 1990; 107: 163–166. - PubMed
    1. Chen L, Xia L, Lu Y, et al.. Influence of periampullary diverticulum on the occurrence of pancreaticobiliary diseases and outcomes of endoscopic retrograde cholangiopancreatography. Eur J Gastroenterol Hepatol 2017; 29: 105–111. - PubMed
    1. Ho JL, Seneviratna A, Yip CHB. Impact of periampullary diverticulum on biliary cannulation: a retrospective cohort study. Adv Dig Med 2023; 10: 232–239.

LinkOut - more resources